Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin
Disease awareness section where you can access information and resources to educate and motivate people living with diabetes
Obesity has been recognised by health organisations including the WHO as a chronic disease that requires long-term management
Haemophilia is an inherited (congenital) bleeding disorder that affects males
Growth Hormone is crucial to the healthy development and functioning of the human body
HRT is used to treat climacteric symptoms of women in different stages of the menopause
Board of Directors and Executive Management
How we are managed, directed and controlled
Novo Nordisk to present 35 abstracts at the International Society on Thrombosis ... Read more
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving se ... Read more
Novo Nordisk A/S: CHMP adopts positive opinion for EU label update of Victoza® b ... Read more
Novo Nordisk A/S: CHMP endorses EU label update of Saxenda® based on the LEADER ... Read more
Novo Nordisk A/S - Share repurchase programme ... Read more
Status regarding Novo Nordisk's holding of its own shares (30 June 2017) ... Read more
Silent period,
Financial statement for the first six months of 2017,
Commerzbank Sector Conference, Frankfurt
EASD 2017, Lisbon
Morgan Stanley Global Healthcare Conference, New York
Take an advanced view of the Novo Nordisk share
Q1 2017 conference call and roadshow presentation
Q2 2017 conference call and roadshow presentation
Read about Novo Nordisk – A focused healthcare company
See relevant content for private investors
Download relevant Investor Relations material
Peter Hugreffe AnkersenHead of Investor Relations
Hanna Ögren Investor Relations Manager
Anders Mikkelsen Investor Relations Manager
Kasper Veje Associate Director IR, North America
Chilie Thomsen Investor Relations Coordinator
Sign up to receive company announcements.
LEADER AdCom conference call and presentation
